Pharmacological analysis of the mode of interaction of McN-A-343 at atrial muscarinic M2 receptors

European Journal of Pharmacology

Volumn 339, Issue 2-3, 1997, Pages 153-156

  Christopoulos, Arthur ^a   Mitchelson, Fred ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Allosteric interaction; McN A 343; Muscarinic receptors; Operational model

Indexed keywords

[4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; CARBACHOL; MUSCARINIC M2 RECEPTOR;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG RECEPTOR BINDING; GUINEA PIG; HEART LEFT ATRIUM; INOTROPISM; NONHUMAN; PRIORITY JOURNAL;

(4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM CHLORIDE; ALLOSTERIC REGULATION; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HEART; HEART ATRIA; MUSCARINIC AGONISTS; MYOCARDIAL CONTRACTION; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC;

EID: 0031588375     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01379-4     Document Type: Article

References (17)

1. Barlow R.B., Scott N.C., Stephenson R.P. The affinity and efficacy of onium salts on the frog rectus abdominus. Br. J. Pharmacol. 31:1967;188-196.
2. Birdsall N.J.M., Burgen A.S.V., Hulme E.C., Stockton J., Zigmond M.J. The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart. Br. J. Pharmacol. 78:1983;257-259.
3. Black J.W., Leff P. Operational models of pharmacological agonism. Proc. Roy. Soc. Lond. B. 220:1983;141-162.
4. 2 muscarine receptors. Mol. Pharmacol. 46:1994;105-114.
5. Ehlert F.J. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Pharmacol. 33:1988;187-194.
6. Elnatan A., Mitchelson F. The interaction of McN-A-343 with muscarine receptors in cardiac and smooth muscle. Biochem. Pharmacol. 46:1993;933-1003.
7. Furchgott R.F. Pharmacological characterization of receptors: Its relation to radioligand-binding studies. Fed. Proc. 37:1978;115-120.
8. Jakubík J., Bacáková L., Lisá V., El-Fakahany E.E., Tucek S. Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc. Natl. Acad. Sci. USA. 93:1996;8705-8709.
9. 2 receptors. Eur. J. Pharmacol. 316:1996;27-32.
10. Lazareno S., Birdsall N.J.M. Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations. Br. J. Pharmacol. 109:1993;1110-1119.
11. Lazareno S., Birdsall N.J.M. Detection, quantitation, and verification of allosteric interactions of agents with labelled and unlabelled ligands at G protein-coupled receptors: Interactions of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol. 48:1995;362-378.
12. Lee N.H., El-Fakahany E.E. Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem. Pharmacol. 42:1991;199-205.
13. Leff P., Harper D., Dainty I.A., Dougall I.G. Pharmacological estimation of agonist affinity: Detection of errors that may be caused by the operation of receptor isomerisation or ternary complex mechanisms. Br. J. Pharmacol. 101:1990;55-60.
14. Motulsky H.J., Ransnas L.A. Fitting curves to data using nonlinear regression: A practical and nonmathematical review. FASEB J. 1:1987;365-374.
15. Tucek S., Proska J. Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 16:1995;205-212.
16. Waelbroeck M. Identification of drugs competing with D-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol. Pharmacol. 46:1994;685-692.
17. Wang S.Z., El-Fakahany E.E. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists. J. Pharmacol. Exp. Ther. 266:1993;237-243.